tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Similar Stocks

Compare
56 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$1.87
$121.81M
-32.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$1.26
$242.03M
162.50%
5 Buy
2 Hold
0 Sell
Moderate Buy
Bluebird Bio
$6.96
$75.83M
-62.80%
2 Buy
5 Hold
1 Sell
Hold
Editas Medicine
$1.37
$113.92M
-80.73%
4 Buy
9 Hold
2 Sell
Hold
Intellia Therapeutics
$10.51
$1.12B
-59.69%
16 Buy
6 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$42.22
$3.71B
-35.76%
10 Buy
3 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
CLYM
Climb Bio
1.87
-0.78
-29.43%
SGMO
Sangamo Biosciences
1.26
0.74
142.31%
BLUE
Bluebird Bio
6.96
-11.84
-62.98%
EDIT
Editas Medicine
1.37
-5.84
-81.00%
NTLA
Intellia Therapeutics
10.51
-16.06
-60.44%
CRSP
Crispr Therapeutics AG
42.22
-24.66
-36.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis